Joel F. Sussman is Chief Accounting Officer of Galera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GRTX, which is worth approximately $0. The most recent transaction as insider was on Nov 13, 2020, when has been sold 10,000 shares (Common Stock) at a price of $10.32 per share, resulting in proceeds of $103,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Joel F. Sussman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 13 2020
SELL
Open market or private sale
$103,200 $10.32 p/Share
10,000 Reduced 100.0%
0 Common Stock
Nov 13 2020
BUY
Exercise of conversion of derivative security
$15,500 $1.55 p/Share
10,000 Added 50.0%
10,000 Common Stock
Nov 12 2020
SELL
Open market or private sale
$100,600 $10.06 p/Share
10,000 Reduced 100.0%
0 Common Stock
Nov 12 2020
BUY
Exercise of conversion of derivative security
$10,700 $1.07 p/Share
10,000 Added 50.0%
10,000 Common Stock
JFS

Joel F. Sussman

Chief Accounting Officer
Malvern, PA

Track Institutional and Insider Activities on GRTX

Follow Galera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTX shares.

Notify only if

Insider Trading

Get notified when an Galera Therapeutics, Inc. insider buys or sells GRTX shares.

Notify only if

News

Receive news related to Galera Therapeutics, Inc.

Track Activities on GRTX